{"transactions":[{"id":1774697,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-22T15:44:37.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":53000,"price":1.3611,"value":72138.3,"ownership":{"direct":false,"nature":"See Notes"},"footnotes":[{"field":"date","element":"transactionDate","label":"F5","text":"Original Form 4 inadvertently identified the date of this transaction as 2/21/2023.  As reported in this amendment, the date of this transaction was 9/21/2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":12674775,"source":{"system":"sec-edgar","filing":"0000935836-23-000621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000093583623000621/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-21"}},{"id":1774696,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-22T15:44:37.000Z","date":"2023-09-20","kind":"purchase","planned":false,"acquired":true,"shares":117100,"price":1.362,"value":159490.2,"ownership":{"direct":false,"nature":"See Notes"},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The Original Form 4 inadvertently identified the date of this transaction as 2/20/2023.  As reported in this amendment, the date of this transaction was 9/20/2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":12621775,"source":{"system":"sec-edgar","filing":"0000935836-23-000621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000093583623000621/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-21"}},{"id":1774695,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-22T15:44:37.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":5143000,"price":1.2562,"value":6460636.6,"ownership":{"direct":false,"nature":"See Notes"},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"On 9/21/2023, the reporting persons filed a Form 4 (the \"Original Form 4\") that inadvertently identified the date of this transaction as 2/19/2023.  As reported in this amendment, the date of this transaction was 9/19/2023. The Original Form 4 also inadvertently identified the date of the earliest transaction reported in the Original Form 4 as 2/19/2023.  As reported in this amendment, the date of the earliest transaction was 9/19/2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":12504675,"source":{"system":"sec-edgar","filing":"0000935836-23-000621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000093583623000621/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-21"}},{"id":1775513,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-21T20:08:36.000Z","date":"2023-02-21","kind":"purchase","planned":false,"acquired":true,"shares":53000,"price":1.3611,"value":72138.3,"ownership":{"direct":false,"nature":"See Notes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":12674775,"source":{"system":"sec-edgar","filing":"0000935836-23-000619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000093583623000619/ownership.xml","form_type":"4"}},{"id":1775512,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-21T20:08:36.000Z","date":"2023-02-20","kind":"purchase","planned":false,"acquired":true,"shares":117100,"price":1.362,"value":159490.2,"ownership":{"direct":false,"nature":"See Notes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":12621775,"source":{"system":"sec-edgar","filing":"0000935836-23-000619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000093583623000619/ownership.xml","form_type":"4"}},{"id":1775511,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-21T20:08:36.000Z","date":"2023-02-19","kind":"purchase","planned":false,"acquired":true,"shares":5143000,"price":1.2562,"value":6460636.6,"ownership":{"direct":false,"nature":"See Notes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":12504675,"source":{"system":"sec-edgar","filing":"0000935836-23-000619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000093583623000619/ownership.xml","form_type":"4"}},{"id":1908441,"issuer":{"id":114006,"kind":"organization","name":"Panacea Acquisition Corp. II","symbol":"PANA"},"owners":[{"id":114007,"kind":"person","name":"EcoR1 Panacea Holdings II, LLC","position":1,"cik":"0001842055","reported_name":"EcoR1 Panacea Holdings II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":2,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":3,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":4,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":5,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":7,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2023-05-02T17:15:46.000Z","date":"2023-04-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":545000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 10, 2023, Panacea Acquisition Corp. II (the \"Company\") announced that it did not consummate an initial business combination by April 9, 2023, the deadline under its Amended and Restated Memorandum and Articles of Association. In connection with the winding up of the Company, the Class A ordinary shares, par value $0.0001 per share, held by the Reporting Persons were surrendered for no consideration on April 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 10, 2023, Panacea Acquisition Corp. II (the \"Company\") announced that it did not consummate an initial business combination by April 9, 2023, the deadline under its Amended and Restated Memorandum and Articles of Association. In connection with the winding up of the Company, the Class A ordinary shares, par value $0.0001 per share, held by the Reporting Persons were surrendered for no consideration on April 28, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting owner, EcoR1 Panacea Holdings II, LLC (the \"Sponsor\"), in whose name the securities reported herein were held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may have been deemed to be a beneficial owner of the shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-026595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919123026595/doc4.xml","form_type":"4"}},{"id":2492213,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}}],"security":"Class A Common Stock","published_at":"2021-11-30T18:07:58.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":21758,"price":7.6859,"value":167229.8122,"ownership":{"direct":false,"nature":"See Notes 2 and 4"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 is the investment adviser to Capital Fund, Qualified Fund and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Capital Fund is the record holder of these securities."}],"balance_after":1169241,"source":{"system":"sec-edgar","filing":"0001567619-21-021329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921021329/doc1.xml","form_type":"4"}},{"id":2492212,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}}],"security":"Class A Common Stock","published_at":"2021-11-30T18:07:58.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":163268,"price":7.6859,"value":1254861.5212,"ownership":{"direct":false,"nature":"See Notes 2 and 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 is the investment adviser to Capital Fund, Qualified Fund and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Qualified Fund is the record holder of these securities."}],"balance_after":7361675,"source":{"system":"sec-edgar","filing":"0001567619-21-021329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921021329/doc1.xml","form_type":"4"}},{"id":2492211,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}}],"security":"Class A Common Stock","published_at":"2021-11-30T18:07:58.000Z","date":"2021-07-31","kind":"sale","acquired":false,"shares":56598,"price":8.64,"value":489006.72,"ownership":{"direct":false,"nature":"See Notes 2 and 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"EcoR1 Capital Fund, L.P. (\"Capital Fund\") and EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") are private investment funds managed by EcoR1 Capital, LLC (\"EcoR1\") on a parri passu basis.  These securities were transferred from Capital Fund to Qualified Fund as part of a periodic rebalancing of the portfolios of the funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 is the investment adviser to Capital Fund, Qualified Fund and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Capital Fund is the record holder of these securities."}],"balance_after":1147483,"source":{"system":"sec-edgar","filing":"0001567619-21-021329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921021329/doc1.xml","form_type":"4"}},{"id":2492210,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}}],"security":"Class A Common Stock","published_at":"2021-11-30T18:07:58.000Z","date":"2021-07-31","kind":"purchase","acquired":true,"shares":56598,"price":8.64,"value":489006.72,"ownership":{"direct":false,"nature":"See Notes 2 and 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"EcoR1 Capital Fund, L.P. (\"Capital Fund\") and EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") are private investment funds managed by EcoR1 Capital, LLC (\"EcoR1\") on a parri passu basis.  These securities were transferred from Capital Fund to Qualified Fund as part of a periodic rebalancing of the portfolios of the funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 is the investment adviser to Capital Fund, Qualified Fund and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Qualified Fund is the record holder of these securities."}],"balance_after":7198407,"source":{"system":"sec-edgar","filing":"0001567619-21-021329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921021329/doc1.xml","form_type":"4"}},{"id":2492209,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}}],"security":"Class A Common Stock","published_at":"2021-11-30T18:07:58.000Z","date":"2021-03-31","kind":"sale","acquired":true,"shares":151544,"price":10.45,"value":1583634.8,"ownership":{"direct":false,"nature":"See Notes 2 and 4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"EcoR1 Capital Fund, L.P. (\"Capital Fund\") and EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") are private investment funds managed by EcoR1 Capital, LLC (\"EcoR1\") on a parri passu basis.  These securities were transferred from Capital Fund to Qualified Fund as part of a periodic rebalancing of the portfolios of the funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 is the investment adviser to Capital Fund, Qualified Fund and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Capital Fund is the record holder of these securities."}],"balance_after":1145600,"source":{"system":"sec-edgar","filing":"0001567619-21-021329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921021329/doc1.xml","form_type":"4"}},{"id":2492208,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Affiliate of Director"}}],"security":"Class A Common Stock","published_at":"2021-11-30T18:07:58.000Z","date":"2021-03-31","kind":"purchase","acquired":true,"shares":151544,"price":10.45,"value":1583634.8,"ownership":{"direct":false,"nature":"See Notes 2 and 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"EcoR1 Capital Fund, L.P. (\"Capital Fund\") and EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") are private investment funds managed by EcoR1 Capital, LLC (\"EcoR1\") on a parri passu basis.  These securities were transferred from Capital Fund to Qualified Fund as part of a periodic rebalancing of the portfolios of the funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 is the investment adviser to Capital Fund, Qualified Fund and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Qualified Fund is the record holder of these securities."}],"balance_after":6735790,"source":{"system":"sec-edgar","filing":"0001567619-21-021329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921021329/doc1.xml","form_type":"4"}},{"id":2750519,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":6,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-13T17:55:30.000Z","date":"2021-04-13","kind":"purchase","acquired":true,"shares":3966,"price":10.271,"value":40734.786,"ownership":{"direct":false,"nature":"See Notes 1 and 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Capital Fund is the record holder of these securities."}],"balance_after":1355625,"source":{"system":"sec-edgar","filing":"0001567619-21-007976","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921007976/doc1.xml","form_type":"4"}},{"id":2750518,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":6,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-13T17:55:30.000Z","date":"2021-04-13","kind":"purchase","acquired":true,"shares":27534,"price":10.271,"value":282801.714,"ownership":{"direct":false,"nature":"See Notes 1 and 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":6990265,"source":{"system":"sec-edgar","filing":"0001567619-21-007976","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921007976/doc1.xml","form_type":"4"}},{"id":2750517,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":6,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-13T17:55:30.000Z","date":"2021-04-12","kind":"purchase","acquired":true,"shares":16745,"price":9.4878,"value":158873.211,"ownership":{"direct":false,"nature":"See Notes 1 and 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Capital Fund is the record holder of these securities."}],"balance_after":1351659,"source":{"system":"sec-edgar","filing":"0001567619-21-007976","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921007976/doc1.xml","form_type":"4"}},{"id":2750516,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":6,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-13T17:55:30.000Z","date":"2021-04-12","kind":"purchase","acquired":true,"shares":116255,"price":9.4878,"value":1103004.189,"ownership":{"direct":false,"nature":"See Notes 1 and 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":6962731,"source":{"system":"sec-edgar","filing":"0001567619-21-007976","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921007976/doc1.xml","form_type":"4"}},{"id":2750515,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":6,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-13T17:55:30.000Z","date":"2021-04-09","kind":"purchase","acquired":true,"shares":37770,"price":10.0306,"value":378855.762,"ownership":{"direct":false,"nature":"See Notes 1 and 3"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Capital Fund is the record holder of these securities."}],"balance_after":1334914,"source":{"system":"sec-edgar","filing":"0001567619-21-007976","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921007976/doc1.xml","form_type":"4"}},{"id":2750514,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":2,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":6,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-13T17:55:30.000Z","date":"2021-04-09","kind":"purchase","acquired":true,"shares":262230,"price":10.0306,"value":2630324.238,"ownership":{"direct":false,"nature":"See Notes 1 and 2"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"EcoR1 Capital, LLC (\"EcoR1\") is the investment adviser to EcoR1 Capital Fund, L.P. (\"Capital Fund\"), EcoR1 Capital Fund Qualified, L.P. (\"Qualified Fund\") and EcoR1 Venture Opportunity Fund, L.P. (\"Venture Fund\"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC (\"Biotech\") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds.  Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Qualified Fund is the record holder of these securities."}],"balance_after":6846476,"source":{"system":"sec-edgar","filing":"0001567619-21-007976","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000156761921007976/doc1.xml","form_type":"4"}},{"id":2750513,"issuer":{"id":114006,"kind":"organization","name":"Panacea Acquisition Corp. II","symbol":"PANA"},"owners":[{"id":114007,"kind":"person","name":"EcoR1 Panacea Holdings II, LLC","position":1,"cik":"0001842055","reported_name":"EcoR1 Panacea Holdings II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":2,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman of the Board"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-04-13T15:10:13.000Z","date":"2021-04-09","kind":"purchase","acquired":true,"shares":545000,"price":10,"value":5450000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, EcoR1 Panacea Holdings II, LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":545000,"source":{"system":"sec-edgar","filing":"0001213900-21-021365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000121390021021365/ownership.xml","form_type":"4"}},{"id":2863832,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":131333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Acquired immediately prior to the closing of the Business Combination pursuant to the forward purchase agreement entered into with Panacea Acquisition Corp. (\"Panacea\") at the time of its initial public offering for a purchase price of $10.00 per one share of Class A common stock and one-third of one warrant to purchase one share of Class A common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"5:00 p.m., New York City time, on February 10, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund, L.P. , which is the owner of record of these securities."}],"balance_after":131333,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-06","underlying":"Class A Common Stock","underlying_shares":131333},"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863831,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":702000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Acquired immediately prior to the closing of the Business Combination pursuant to the forward purchase agreement entered into with Panacea Acquisition Corp. (\"Panacea\") at the time of its initial public offering for a purchase price of $10.00 per one share of Class A common stock and one-third of one warrant to purchase one share of Class A common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"5:00 p.m., New York City time, on February 10, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund Qualified, L.P., which is the record owner of these securities."}],"balance_after":702000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-06","underlying":"Class A Common Stock","underlying_shares":702000},"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863830,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Liability Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Warrants included in units purchased in a private placement by EcoR1 Panacea Holdings, LLC for $10.00 per unit in connection with Panacea's initial public offering. Each unit consisted of one share of Class A common stock and one-third of one warrant to purchase one share of Class A common stock. Upon the closing of the Business Combination, the warrants may be deemed to be derivative securities for purposes of Section 16."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"5:00 p.m., New York City time, on February 10, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 Panacea Holdings, LLC, which is the owner of record of these securities, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by EcoR1 Panacea Holdings, LLC but each (other than EcoR1 Panacea Holdings, LLC) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":130000,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-06","underlying":"Class A Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863829,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"exercise","acquired":false,"shares":2775000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Liability Company"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock owned prior to the Business Combination (as defined below) was  converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of EcoR1 Panacea Holdings, LLC (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock owned prior to the Business Combination (as defined below) was  converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of EcoR1 Panacea Holdings, LLC (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock owned prior to the Business Combination (as defined below) was  converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of EcoR1 Panacea Holdings, LLC (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 Panacea Holdings, LLC, which is the owner of record of these securities, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by EcoR1 Panacea Holdings, LLC but each (other than EcoR1 Panacea Holdings, LLC) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2775000},"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863828,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":2200627,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea, Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (such transaction, the \"Business Combination\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Oleg Nodelman is the manager of EcoR1 Venture Opportunity Fund, LP, which is the owner of record of these securities."}],"balance_after":2200627,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863827,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":515879,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea, Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (such transaction, the \"Business Combination\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund, L.P. , which is the owner of record of these securities."}],"balance_after":1297144,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863826,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":2365511,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea, Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (such transaction, the \"Business Combination\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund Qualified, L.P., which is the record owner of these securities."}],"balance_after":6584246,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863825,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":387265,"price":10,"value":3872650.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Acquired pursuant to one of a number of subscription agreements that Panacea entered into with various investors pursuant to which such investors agreed to purchase, immediately prior to the closing of the Business Combination (as defined below), an aggregate of 47,655,000 shares of Class A Common Stock at a price of $10.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund, L.P. , which is the owner of record of these securities."}],"balance_after":781265,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863824,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":2112735,"price":10,"value":21127350.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Acquired pursuant to one of a number of subscription agreements that Panacea entered into with various investors pursuant to which such investors agreed to purchase, immediately prior to the closing of the Business Combination (as defined below), an aggregate of 47,655,000 shares of Class A Common Stock at a price of $10.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund Qualified, L.P., which is the record owner of these securities."}],"balance_after":4218735,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863823,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":394000,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Acquired immediately prior to the closing of the Business Combination pursuant to the forward purchase agreement entered into with Panacea Acquisition Corp. (\"Panacea\") at the time of its initial public offering for a purchase price of $10.00 per one share of Class A common stock and one-third of one warrant to purchase one share of Class A common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund, L.P. , which is the owner of record of these securities."}],"balance_after":394000,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863822,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":2106000,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Acquired immediately prior to the closing of the Business Combination pursuant to the forward purchase agreement entered into with Panacea Acquisition Corp. (\"Panacea\") at the time of its initial public offering for a purchase price of $10.00 per one share of Class A common stock and one-third of one warrant to purchase one share of Class A common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Oleg Nodelman is the manager of EcoR1 Capital Fund Qualified, L.P., which is the record owner of these securities."}],"balance_after":2106000,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":2863821,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":1,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":2,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-02-12T20:59:06.000Z","date":"2021-02-10","kind":"exercise","acquired":true,"shares":2775000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Liability Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock owned prior to the Business Combination (as defined below) was  converted into one share of Class A Common Stock; the Class B Common Stock was convertible at any time at the election of EcoR1 Panacea Holdings, LLC (or would have automatically converted at the time of the issuer's initial business combination if not yet converted at such time) with no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"EcoR1 Panacea Holdings, LLC, which is the owner of record of these securities, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by EcoR1 Panacea Holdings, LLC but each (other than EcoR1 Panacea Holdings, LLC) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":3165000,"source":{"system":"sec-edgar","filing":"0001209191-21-010503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919121010503/doc4.xml","form_type":"4"}},{"id":3089135,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":140308,"kind":"organization","name":"EcoR1 Panacea Holdings, LLC","position":1,"cik":"0001816134","reported_name":"EcoR1 Panacea Holdings, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":2,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman of the Board"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A common stock","published_at":"2020-07-06T17:06:28.000Z","date":"2020-07-06","kind":"purchase","acquired":true,"shares":390000,"price":10,"value":3900000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are included within the 390,000 private placement units of the issuer purchased by EcoR1 Panacea Holdings, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the issuer's initial public offering, and each such unit consists of one share of Class A common stock of the issuer and one-third of one redeemable warrant of the issuer. The warrants included in the units will become exercisable, if at all, on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the issuer' initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting owner, the Sponsor, in whose name the securities reported herein are held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":390000,"source":{"system":"sec-edgar","filing":"0001213900-20-016762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000121390020016762/ownership.xml","form_type":"4"}},{"id":3698125,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T23:32:38.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":83540,"price":13.16,"value":1099386.4,"ownership":{"direct":true},"balance_after":4408097,"source":{"system":"sec-edgar","filing":"0001567619-19-000984","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761919000984/doc1.xml","form_type":"4"}},{"id":3698124,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T23:32:38.000Z","date":"2018-12-19","kind":"purchase","acquired":true,"shares":51879,"price":13.84,"value":718005.36,"ownership":{"direct":true},"balance_after":4324557,"source":{"system":"sec-edgar","filing":"0001567619-19-000984","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761919000984/doc1.xml","form_type":"4"}},{"id":3698123,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T23:32:38.000Z","date":"2018-12-18","kind":"purchase","acquired":true,"shares":78469,"price":13.82,"value":1084441.58,"ownership":{"direct":true},"balance_after":4272678,"source":{"system":"sec-edgar","filing":"0001567619-19-000984","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761919000984/doc1.xml","form_type":"4"}},{"id":3698122,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T23:32:38.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":26520,"price":13.2,"value":350064.0,"ownership":{"direct":true},"balance_after":4194209,"source":{"system":"sec-edgar","filing":"0001567619-19-000984","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761919000984/doc1.xml","form_type":"4"}},{"id":3732019,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T23:26:31.000Z","date":"2018-12-13","kind":"purchase","acquired":true,"shares":25217,"price":13.89,"value":350264.13,"ownership":{"direct":true},"balance_after":4220729,"source":{"system":"sec-edgar","filing":"0001567619-18-007956","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761918007956/doc1.xml","form_type":"4"}},{"id":3732018,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T23:26:31.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":15321,"price":13.9089,"value":213098.2569,"ownership":{"direct":true},"balance_after":4195512,"source":{"system":"sec-edgar","filing":"0001567619-18-007956","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761918007956/doc1.xml","form_type":"4"}},{"id":3741235,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T00:14:57.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":17079,"price":13.49,"value":230395.71,"ownership":{"direct":true},"balance_after":4180919,"source":{"system":"sec-edgar","filing":"0001567619-18-007453","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761918007453/doc1.xml","form_type":"4"}},{"id":3741234,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T00:14:57.000Z","date":"2018-12-04","kind":"purchase","acquired":true,"shares":54645,"price":13.08,"value":714756.6,"ownership":{"direct":true},"balance_after":4163112,"source":{"system":"sec-edgar","filing":"0001567619-18-007453","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761918007453/doc1.xml","form_type":"4"}},{"id":3741233,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T00:14:57.000Z","date":"2018-12-03","kind":"purchase","acquired":true,"shares":48182,"price":13.97,"value":673102.54,"ownership":{"direct":true},"balance_after":4108467,"source":{"system":"sec-edgar","filing":"0001567619-18-007453","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000156761918007453/doc1.xml","form_type":"4"}},{"id":3930428,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T21:15:14.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":2733231,"price":0.8111,"value":2216923.6641,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-18-024271","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036118024271/doc1.xml","form_type":"4"}},{"id":3930427,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T21:15:14.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":121294,"price":1.4268,"value":173062.2792,"ownership":{"direct":true},"balance_after":2733231,"source":{"system":"sec-edgar","filing":"0001140361-18-024271","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036118024271/doc1.xml","form_type":"4"}},{"id":3930426,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-16T21:15:14.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":354791,"price":1.7167,"value":609069.7097,"ownership":{"direct":true},"balance_after":2854525,"source":{"system":"sec-edgar","filing":"0001140361-18-024271","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036118024271/doc1.xml","form_type":"4"}},{"id":3960979,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Options","published_at":"2018-04-18T17:29:22.000Z","date":"2018-04-17","kind":"purchase","acquired":true,"shares":246,"price":8.5,"value":2091.0,"ownership":{"direct":true},"balance_after":1213,"derivative":{"exercise_price":60,"exercise_date":"2018-04-17","expiration_date":"2018-11-16","underlying":"Common Stock","underlying_shares":24600},"source":{"system":"sec-edgar","filing":"0001140361-18-018902","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114036118018902/doc1.xml","form_type":"4"}},{"id":3962069,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Options","published_at":"2018-04-17T20:05:53.000Z","date":"2018-04-13","kind":"purchase","acquired":true,"shares":967,"price":7.473,"value":7226.391,"ownership":{"direct":true},"balance_after":967,"derivative":{"exercise_price":60,"exercise_date":"2018-04-13","expiration_date":"2018-11-16","underlying":"Common Stock","underlying_shares":96700},"source":{"system":"sec-edgar","filing":"0001140361-18-018797","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114036118018797/doc1.xml","form_type":"4"}},{"id":4131379,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T20:46:42.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":1083,"price":3.95,"value":4277.85,"ownership":{"direct":true},"balance_after":3209316,"source":{"system":"sec-edgar","filing":"0001140361-17-046221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036117046221/doc1.xml","form_type":"4"}},{"id":4131378,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T20:46:42.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":5860,"price":4.0008,"value":23444.688,"ownership":{"direct":true},"balance_after":3210399,"source":{"system":"sec-edgar","filing":"0001140361-17-046221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036117046221/doc1.xml","form_type":"4"}},{"id":4131377,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T20:46:42.000Z","date":"2017-11-09","kind":"sale","acquired":false,"shares":5819,"price":4.1504,"value":24151.1776,"ownership":{"direct":true},"balance_after":3216259,"source":{"system":"sec-edgar","filing":"0001140361-17-046221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036117046221/doc1.xml","form_type":"4"}},{"id":4131376,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T20:46:42.000Z","date":"2017-11-08","kind":"sale","acquired":false,"shares":1070,"price":4.3,"value":4601.0,"ownership":{"direct":true},"balance_after":3222078,"source":{"system":"sec-edgar","filing":"0001140361-17-046221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036117046221/doc1.xml","form_type":"4"}},{"id":4131375,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T20:46:42.000Z","date":"2017-11-01","kind":"purchase","acquired":true,"shares":24728,"price":4.8,"value":118694.4,"ownership":{"direct":true},"balance_after":3223148,"source":{"system":"sec-edgar","filing":"0001140361-17-046221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036117046221/doc1.xml","form_type":"4"}},{"id":4131374,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":1,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T20:46:42.000Z","date":"2017-10-01","kind":"purchase","acquired":true,"shares":4879,"price":5.05,"value":24638.95,"ownership":{"direct":true},"balance_after":3198420,"source":{"system":"sec-edgar","filing":"0001140361-17-046221","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000114036117046221/doc1.xml","form_type":"4"}}]}